Clinical Trial Update: To Study Generic Tacrolimus Ointment, 0.1% in the Treatment of Moderate to Severe Atopic Dermatitis (Inflammation of Skin: Itchy, Red, Swollen, and Cracked Skin) [Phase 3]

View source ↗

Summary

Phase 3 trial investigating 0.1% tacrolimus ointment for moderate to severe atopic dermatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Tacrolimus Ointment (0.1%) (tacrolimus)

Snippet

Sponsor: Glenmark Pharmaceuticals Ltd. India | Conditions: Atopic Dermatitis | Phase 3 | Status: COMPLETED